Healthcare & Life Sciences Industry Updates

Google News – Pharmaceuticals External News

ArrowMark Colorado Holdings (PMVP) holds 3.67% stake in PMV Pharmaceuticals - Stock Titan

news.google.com · 11 Jul 2026

Google News – Pharmaceuticals External News

ANI Pharmaceuticals (ANIP) Recalls HydrOXYzine Solution, Is The Pullback A Valuation Opportunity? - simplywall.st

news.google.com · 11 Jul 2026

Google News – Pharmaceuticals External News

FDA Approves Subcutaneous Sarclisa Escena | PharmExec - Pharmaceutical Executive

news.google.com · 11 Jul 2026

Google News – Pharmaceuticals External News

Alnylam Pharmaceuticals (ALNY) Could Be 28% Undervalued Following Rival ATTR Trial Failure - simplywall.st

news.google.com · 11 Jul 2026

Google News – Pharmaceuticals External News

Vertex Pharmaceuticals Just Made a $10 Billion Move. Is the Stock a Buy? - Yahoo Finance

news.google.com · 11 Jul 2026

Google News – Pharmaceuticals External News

How CHMP’s Positive Rett Syndrome Ruling on DAYBU Could Impact ACADIA Pharmaceuticals (ACAD) Investors - Yahoo! Finance Canada

news.google.com · 11 Jul 2026

Google News – Pharmaceuticals External News

If You Invested $1000 in Vertex Pharmaceuticals a Decade Ago, This is How Much It'd Be Worth Now - Yahoo Finance Australia

news.google.com · 11 Jul 2026

Google News – Pharmaceuticals External News

Explosive Growth in Generative AI in Pharmaceuticals: Market Set to Reach $9.36 Billion by 2030 at 30.9% CAGR - GlobeNewswire

news.google.com · 11 Jul 2026

Google News – Pharmaceuticals External News

InMed Pharmaceuticals Updates Mentari Merger Terms, Adding PIPE Option and Confirming Tax Reorganization - TradingView

news.google.com · 11 Jul 2026

Google News – Pharmaceuticals External News

Reviva Pharmaceuticals Holdings (NASDAQ: RVPH) — Files Form 25 to remove Common Stock from Nasdaq listing - Stock Titan

news.google.com · 11 Jul 2026

Google News – Pharmaceuticals External News

Healthcare Investing: Finding Growth Beyond Pharmaceuticals - AllianceBernstein - Commentaries - Advisor Perspectives

news.google.com · 11 Jul 2026

Google News – Pharmaceuticals External News

Hepion Pharmaceuticals (HEPA) director Stetz submits initial insider Form 3 - Stock Titan

news.google.com · 11 Jul 2026

Google News – Pharmaceuticals External News

Is This Biotech Stock a Buy Near Its 52-Week High? - The Motley Fool

news.google.com · 11 Jul 2026

Google News – Pharmaceuticals External News

LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance Singapore

news.google.com · 11 Jul 2026

Google News – Pharmaceuticals External News

Vertex Pharmaceuticals Just Made a $10 Billion Move. Is the Stock a Buy? - The Motley Fool

news.google.com · 11 Jul 2026

News & Articles

Cancer Is Rarely Caused By One Mistake: Why Healthcare Professionals Must Improve Public Understanding

Beyond AI: Why Human Empathy Will Remain Healthcare's Most Valuable Skill

Why healthcare providers are sidelining employees amid coronavirus pandemic

For adults with prediabetes, lifestyle intervention lowered risk of developing multiple chronic conditions

New Alzheimer’s blood test may tell when symptoms are around the corner

4 takeaways from MDUFA VI draft agreement

J&J wins FDA approval for dual-energy ablation catheter

Physicians’ wearable data use hampered by reimbursement, workflow barriers: survey

Vacancy: National Consultant (NO C) to strengthen maternal and newborn health systems.

Stanford Health Care Tri-Valley launches hospital expansion - Stanford Medicine

HHSC, UT Southwestern Medical Center celebrate opening of new psychiatric hospital in Dallas - UT Southwestern Medical

Hospital and health system leaders participate in Healthcare of Tomorrow Conference - American Hospital Association

HCA Healthcare hospitals earn 26 Press Ganey Human Experience Awards for patient experience - HCA Healthcare Today

CEO Nancy Brown named to Becker’s Hospital Review’s 2026 “Great Leaders in Healthcare” list - www.heart.org

Enhancing healthcare workers’ safety and well-being through a comprehensive qualitative analysis across hospital settings - Nature

Providers race to scale hospital-at-home before reimbursement changes - Modern Healthcare

One or Two Health Systems Controlled the Entire Market for Inpatient Hospital Care in Nearly Half of Metropolitan Areas in 2024 - KFF

How the hospital-at-home program offers alternative care as demand surges - investigatetv.com

Layoffs, closures tracker: Adventist Health cuts 132 jobs - Modern Healthcare

Experts: Cuts to federal student loans could hurt first generation students, healthcare industry - MPR News

ArrowMark Colorado Holdings (PMVP) holds 3.67% stake in PMV Pharmaceuticals - Stock Titan

ANI Pharmaceuticals (ANIP) Recalls HydrOXYzine Solution, Is The Pullback A Valuation Opportunity? - simplywall.st

FDA Approves Subcutaneous Sarclisa Escena | PharmExec - Pharmaceutical Executive

Alnylam Pharmaceuticals (ALNY) Could Be 28% Undervalued Following Rival ATTR Trial Failure - simplywall.st

Vertex Pharmaceuticals Just Made a $10 Billion Move. Is the Stock a Buy? - Yahoo Finance

How CHMP’s Positive Rett Syndrome Ruling on DAYBU Could Impact ACADIA Pharmaceuticals (ACAD) Investors - Yahoo! Finance Canada

If You Invested $1000 in Vertex Pharmaceuticals a Decade Ago, This is How Much It'd Be Worth Now - Yahoo Finance Australia

Explosive Growth in Generative AI in Pharmaceuticals: Market Set to Reach $9.36 Billion by 2030 at 30.9% CAGR - GlobeNewswire

InMed Pharmaceuticals Updates Mentari Merger Terms, Adding PIPE Option and Confirming Tax Reorganization - TradingView

Reviva Pharmaceuticals Holdings (NASDAQ: RVPH) — Files Form 25 to remove Common Stock from Nasdaq listing - Stock Titan

Healthcare Investing: Finding Growth Beyond Pharmaceuticals - AllianceBernstein - Commentaries - Advisor Perspectives

Hepion Pharmaceuticals (HEPA) director Stetz submits initial insider Form 3 - Stock Titan

Is This Biotech Stock a Buy Near Its 52-Week High? - The Motley Fool

LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance Singapore

Vertex Pharmaceuticals Just Made a $10 Billion Move. Is the Stock a Buy? - The Motley Fool